Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05355311 · ClinicalTrials.gov registry record · Phase 1
Enhancing the Effects of Alcohol Treatment With L-Carnitine
A Phase 1 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT05355311 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 24 participants.
The verdict
NCT05355311, a Phase 1 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effects of L-carnitine, 2.97g daily on alcohol cue-elicited alcohol craving during a human laboratory paradigm after 4 weeks of daily dosing among participants ages 18-25 with alcohol use disorder (AUD) as confirmed by the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5™) and who report at least mild depressive symptoms on the Beck Depression Inventory-II. Secondary objectives include evaluation of L-carnitine (2.97g/day) on alcohol craving and use, subjective effects of alcohol consumption, mood, sleep, alcohol use negative consequences, study retention, and safety and tolerability.
Interventions
- DRUG L-carnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-09-27 |
| Est. Completion | 2025-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05355311
The ClinicalTrials.gov registry entry for NCT05355311 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-carnitine is the first listed.
NCT05355311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05355311 about?
NCT05355311 is a clinical study titled "Enhancing the Effects of Alcohol Treatment With L-Carnitine". The primary objective of this study is to evaluate the effects of L-carnitine, 2.97g daily on alcohol cue-elicited alcohol craving during a human laboratory paradigm after 4 weeks of daily dosing among participants ages 18-25 with alcohol use disorder (AUD) as confirmed by the Diagnostic and Statist...
What is the current status of trial NCT05355311?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2024-09-27. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05355311?
The interventions under investigation include: L-carnitine (DRUG).
Who is sponsoring clinical trial NCT05355311?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.